Description:

This course will examine new findings pertaining to the diagnosis and management of central serious chorioretinopathy (CSCR) and what they mean for the practicing optometrist.  Key findings from recent studies will be discussed in order to provide an update on the etiology, manifestations, and pathophysiology of this condition.  We will also discuss the role of newer technologies such as enhanced depth imaging and OCT angiography on diagnosis.  Lastly, novel treatment options, including mineralocorticoid antagonist medications and subthreshold micropulse laser, will be assessed and incorporated into a current evidence-based management plan for various presentations of CSCR.

Course Code:

AOA115-PS

Speaker(s):

James Rogala, O.D.
jamesrogala@upike.edu

Credits:

1

AOA Expiration Date:

3/30/2024

Related News

Seeing the eclipse, and the AOA, everywhere

Ahead of this year’s total solar eclipse, the AOA and doctors of optometry jumped in early and often to educate the public about eye safety.

Does your practice do in-house billing? Here’s something to know

Save 10 hours, see 11 more patients each week—that’s how much time doctors say they recapture weekly by delegating nonphysician tasks to well-trained or certified staff.

Protecting patient privacy when a clinical observer visits

An optometry student is shadowing you at your practice. Does your patient need to give their consent?